Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Shelter Pharma
Join Channel
Consolidated Standalone

Shelter Pharma

₹58.5 1.9 | 3.4%

Market Cap ₹68 Cr.

Stock P/E

P/B 2.3

Current Price ₹58.5

Book Value ₹ 25.6

Face Value 10

52W High ₹80.9

Dividend Yield 0%

52W Low ₹ 37.5

Edit Ratio

Shelter Pharma Research see more...

Overview Inc. Year: 2007Industry: Pharmaceuticals & Drugs

Shelter Pharma Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Shelter Pharma Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Shelter Pharma Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 21 23 25 28 30 31 28 30 22 30 36
Other Income 0 0 0 0 1 0 0 0 0 0 0
Total Income 21 23 25 28 31 31 28 30 22 30 36
Total Expenditure 19 21 25 28 31 31 28 30 22 27 28
Operating Profit 2 2 0 0 0 0 0 0 0 3 8
Interest 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 2 0 0 0 0 0 0 0 3 8
Provision for Tax 1 1 0 0 0 0 0 0 0 1 2
Profit After Tax 1 2 0 0 0 0 0 0 0 2 6
Adjustments 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 2 0 0 0 0 0 0 0 2 6
Adjusted Earnings Per Share 1.9 2.3 0 0.1 0.1 0.1 0.1 0.1 0.1 2.4 7.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 20% 6% 3% 6%
Operating Profit CAGR 167% 0% 0% 15%
PAT CAGR 200% 0% 0% 20%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 54% 27% 17% 12%
ROCE Average 67% 35% 22% 14%

Shelter Pharma Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 9 11 8 8 8 8 8 7 7 9 15
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 4 5 4 4 4 3 3 3 3 4 6
Total Liabilities 13 16 11 12 12 11 11 11 10 13 21
Fixed Assets 2 2 3 3 3 3 3 2 2 1 2
Other Non-Current Assets 0 0 0 0 0 0 1 1 1 2 1
Total Current Assets 11 13 9 9 9 8 8 8 8 10 19
Total Assets 13 16 11 12 12 11 11 11 10 13 21

Shelter Pharma Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 0 0 0 0 -0 0 0 -0 -0 1 0
Cash Flow from Investing Activities 0 0 0 0 -0 -0 0 0 0 -1 0
Cash Flow from Financing Activities 0 0 0 0 1 -0 0 0 0 0 0
Net Cash Inflow / Outflow 0 0 0 0 -0 -0 0 0 0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Shelter Pharma Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 1.9 2.3 0.03 0.06 0.07 0.07 0.08 0.11 0.05 2.37 7.47
CEPS(Rs) 1.94 2.35 0.16 0.2 0.17 0.21 0.25 0.29 0.2 2.59 7.68
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 10.63 12.94 8.75 8.74 8.75 8.54 8.63 8.19 7.97 10.31 17.52
Core EBITDA Margin(%) 10.28 10.44 0.37 0.56 -2.3 0.52 0.66 0.81 0.85 9.1 22.31
EBIT Margin(%) 10.31 10.35 0.11 0.21 0.22 0.23 0.31 0.38 0.36 8.6 21.87
Pre Tax Margin(%) 9.52 10.35 0.1 0.19 0.2 0.22 0.29 0.35 0.28 8.34 21.8
PAT Margin (%) 6.53 7.22 0.08 0.17 0.16 0.17 0.22 0.27 0.18 6.11 16
Cash Profit Margin (%) 6.65 7.38 0.46 0.52 0.4 0.49 0.64 0.71 0.7 6.67 16.45
ROA(%) 12.01 11.67 0.15 0.41 0.41 0.49 0.55 0.74 0.4 15.94 33.73
ROE(%) 26.4 19.54 0.26 0.74 0.75 0.87 0.96 1.31 0.68 25.95 53.66
ROCE(%) 25.25 22.5 0.28 0.71 0.9 1.16 1.33 1.84 1.29 36.17 67.38
Receivable days 66.14 61.36 39.64 13.9 13.13 10.17 4.32 4.11 11.15 14.36 49.47
Inventory Days 46.3 73.9 68.11 55.25 50.7 44.77 52.22 51.18 67.55 58.83 68.85
Payable days 8.34 10.91 6.06 2.33 2.24 2.01 2.4 2.87 4.93 4.48 5.47
PER(x) 0 0 0 0 0 0 0 0 0 0 0
Price/Book(x) 0 0 0 0 0 0 0 0 0 0 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.12 0.09 0.1 0.09 0.02 0.01 0.02 0.02 0.01 0.02 0.25
EV/Core EBITDA(x) 1.14 0.88 19.67 15.26 3.47 2.61 2.41 2.23 0.6 0.19 1.13
Net Sales Growth(%) 13.62 9.31 8.32 12.32 6.62 4.86 -11.86 8.42 -25.22 33.68 20.29
EBIT Growth(%) 25.57 9.79 -98.82 111.62 12.01 10.25 14.57 36.69 -30.86 3131.13 205.89
PAT Growth(%) 51.8 21.07 -98.78 130.47 0.46 15.02 10.49 33.49 -48.69 4358.74 214.82
EPS Growth(%) 33.75 21.07 -98.78 130.47 0.46 15.02 10.49 33.49 -51.87 4358.74 214.83
Debt/Equity(x) 0.27 0.22 0.33 0.33 0.02 0.01 0.02 0.04 0 0.02 0.13
Current Ratio(x) 2.87 2.8 2.42 2.36 2.29 2.51 2.37 2.33 2.71 2.65 2.98
Quick Ratio(x) 1.82 1.69 1.27 1.17 1.25 1.28 1.09 1.08 1.33 1.12 1.71
Interest Cover(x) 13.03 2441.2 8.44 10.47 10.52 15.14 19.49 12.05 4.62 32.6 313.77
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Shelter Pharma Shareholding Pattern

# Sep 2023 Mar 2024
Promoter 56.89 56.89
FII 0 0
DII 0 0
Public 43.11 43.11
Others 0 0
Total 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 27%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 4.48 to 5.47days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Shelter Pharma News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!